Table 1.
Basic information of eligible articles.
| Author (ref.) | Year | Country | Study design | Age, y | Test confirming infection | Duration of dialysis, m | Dialysis type, n | HP(+), n | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HD | CAPD | Controls | Dialysis | |||||||
| Shousha et al. [13] | 1990 | UK | Case-control | HP(+) 54 ± 14.3 HP(−) 48 ± 14.2 |
Warthin-Starry, Giemsa | NG | NG | NG | 51/120 | 12/50 |
| Jaspersen et al. [10] | 1995 | Germany | Case-control | 58.2 ± 12.6 | Urease test, Giemsa | NG | 7/34 | 0 | 47/127 | 7/34 |
| Krawczyk et al. [14] | 1996 | Poland | Case-control | 36.8 ± 13.2 | Urease test, Giemsa | 28 ± 12.2 | 13/21 | 0 | 14/22 | 13/21 |
| Ozgür et al. [15] | 1997 | Turkey | Case-control | 37.27 ± 14.08 | Urease test | 28.87 ± 28.92 | 28/47 | 0 | 64/100 | 28/47 |
| Gür et al. [21] | 1999 | Turkey | Case-control | HP(+) 35.1 ± 4.2 HP(−) 32.5 ± 5.3 |
Urease test, histology | HP(+) 21.2 ± 16.4 HP(−) 21.8 ± 11.4 |
25/45 | 0 | 24/44 | 25/45 |
| Araki et al. [4] | 1999 | Japan | Case-control | 57.4 ± 12.8 | Histology, culture | 91.2 ± 62.4 | NG/54 | NG/9 | 42/64 | 29/63 |
| Yildiz et al. [22] | 1999 | Turkey | Cross-sectional | 36.6 ± 15.2 | ELISA (IgG) | 32.5 ± 27.7 | NG | NG | 39/55 | 31/47 |
| Tamura et al. [23] | 1999 | Japan | Case-control | 52.2 ± 1.8 | Urease test, histology, and culture | 29.3 ± 5.4 | 20/41 | 5/8 | 26/48 | 25/49 |
| Blusiewicz et al. [24] | 2005 | Poland | Case-control | 50.8 ± 2.9 | Urease test, histology | NG | 19/30 | 0 | 22/31 | 19/30 |
| Khedmat et al. [6] | 2007 | Iran | Case-control | 47.9 ± 3.5 | Urease test | 46.9 ± 10.7 | 46/73 | 0 | 106/305 | 46/73 |
| Khazaei et al. [25] | 2008 | Iran | Case-control | 14.7 ± 3.4 | Urease test, histology | HP(+) 22.5 ± 18.5 HP(−) 26.9 ± 32.5 |
16/24 | 0 | 5/25 | 16/24 |
| Gioè et al. [26] | 2008 | Italy | Case-control | NG | RUT, Giemsa | NG | 75/142 | 0 | 59/132 | 75/142 |
| Asl and Nasri [27] | 2009 | Iran | Cross-sectional | 56 ± 14 | Giemsa | ≥6 | 28/40 | 0 | 23/40 | 28/40 |
| Sugimoto et al. [11] | 2009 | Japan | Case-control | 58.8 ± 0.4 | ELISA (IgG) | 100.8 ± 3.6 | NG | NG | 314/400 | 262/539 |
| Chang et al. [28] | 2010 | Korea | Case-control | 62 ± 9.8 | RUT, histology | HP(+) 56.8 ± 26.9 HP(−) 66.4 ± 26.1 |
12/33 | 0 | 36/55 | 12/33 |
Ref.: reference; HD: hemodialysis; CAPD: continuous ambulatory peritoneal dialysis; NG: not given; RUT: rapid urease test.